• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Epidemiological and clinical characteristics of humans with avian influenza A (H7N9) infection in Guangdong, China, 2013-2017

tetano

Editor, Senior Moderator
Int J Infect Dis. 2017 Nov 8. pii: S1201-9712(17)30200-X. doi: 10.1016/j.ijid.2017.07.021. [Epub ahead of print]
[h=1]Epidemiological and clinical characteristics of humans with avian influenza A (H7N9) infection in Guangdong, China, 2013-2017.[/h] Yang Y[SUP]1[/SUP], Zhong H[SUP]1[/SUP], Song T[SUP]1[/SUP], He J[SUP]1[/SUP], Guo L[SUP]2[/SUP], Tan X[SUP]1[/SUP], Huang G[SUP]1[/SUP], Kang M[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]OBJECTIVE:[/h] To describe the demographics and clinical characteristics of patients with A (H7N9) infection, to test the differences in the distribution of demographics and clinical characteristics by clinical severity, and to explore potential factors associated with clinical severity.
[h=4]METHODS:[/h] This retrospective study was conducted to collect epidemiological and clinical information regarding the confirmed cases in Guangdong through field investigation and review of medical records.
[h=4]RESULTS:[/h] Of the 256 cases, 100 (39.0%) patients died, and 168 (65.6%) patients were admitted to ICUs. The male-to-female ratio was approximately 2.0:1, and the median age was 56 years (range, 1 to 88). Among the 215 patients accepting oseltamivir treatment, the median time from the onset of illness to oseltamivir treatment was 5days (range, 0 to 16); 35 patients received zanamivir treatment after a median of 8days (range, 0 to 23). The univariable logistic regression models demonstrated that time from the onset of illness to oseltamivir treatment (OR=1.10, 95% CI=1.01-1.10) and zanamivir treatment (OR=1.05, 95% CI=1.02-1.07) were associated with the death of patients.
[h=4]CONCLUSIONS:[/h] Preventive measures should focus on high-risk populations, such as the elderly and the groups with high frequency exposure to live poultry. Earlier oseltamivir and zanamivir treatment were recommended.
Copyright ? 2017 The Author(s). Published by Elsevier Ltd.. All rights reserved.


[h=4]KEYWORDS:[/h] Avian influenza; Clinical characteristics; Epidemiological characteristics; H7N9 subtype

PMID: 29128273 DOI: 10.1016/j.ijid.2017.07.021
Free full text
 
Back
Top Bottom